Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $26.44 which represents a slight increase of $0.43 or 1.65% from the prior close of $26.01. The stock opened at $26.01 and touched a low ...

Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health agencies, among other moves that have sent waves through the biopharma industry.

If he’s confirmed as health secretary, Robert F. Kennedy Jr. will have broad authority to pursue an anti-vaccine agenda.

M&A activity in the F&B industry is set to rise in 2025, driven by favorable economic conditions and strategic acquisitions ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

Here are three dividend stocks that retirees can buy with confidence as they offer recurring, dependable payouts and a degree ...

Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...

The Hancock County Commission will be receiving additional funds as part of an antitrust lawsuit filed by the State of West ...

The Hancock County Commission has been informed by the West Virginia Attorney General's Office that it will receive $30,000 in the first quarter of 2025.The pay ...

Corporation, a biopharmaceutical company specializing in proprietary therapeutics with a market capitalization of $14 billion ...

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in ...

Pfizer Inc. closed 16.17% below its 52-week high of $31.54, which the company achieved on July 30th.